https://grail.com/manuscripts/molecular-cancer-signal-localization-in-mced-testing-minimizes-radiation-and-imaging-burden-compared-with-whole-body-imaging-approaches/ 2026-05-14T16:57:41+00:00 https://grail.com/manuscripts/early-cancer-detection-in-a-large-american-cancer-society-cohort-study-retrospective-analysis-of-methylated-dna-biomarkers/ 2026-04-27T21:31:18+00:00 https://grail.com/manuscripts/preclinical-circulating-tumor-dna-shedding-duration-and-prognostic-implications-of-modeling-3669-patients-with-cancer-in-the-american-cancer-society-cancer-prevention-study-3-and-circulating-cell-free/ 2026-04-27T21:30:14+00:00 https://grail.com/manuscripts/prognostic-significance-of-blood-based-multicancer-detection-in-circulating-tumor-dna-five-year-outcomes-analysis/ 2026-04-27T21:28:47+00:00 https://grail.com/manuscripts/prevalence-of-brca1-promoter-methylation-in-cohorts-of-individuals-with-and-without-cancer-assessed-by-circulating-cell-free-dna/ 2026-03-09T06:29:22+00:00 https://grail.com/manuscripts/influence-of-stage-at-cancer-diagnosis-on-nhs-hospital-care-costs-in-england-a-national-retrospective-population-based-cohort-study-using-individual-patient-level-data/ 2026-02-16T11:32:00+00:00 https://grail.com/manuscripts/modelled-impact-of-a-multi-cancer-early-detection-screening-programme-on-the-demand-for-diagnostics-in-england/ 2026-01-31T08:42:04+00:00 https://grail.com/manuscripts/generic-protocols-for-analytical-validation-of-tumor-informed-circulating-tumor-dna-assays-for-molecular-residual-disease-the-blood-profiling-atlas-in-cancers-molecular-residual-disease-analytical/ 2026-01-14T08:40:29+00:00 https://grail.com/manuscripts/multicancer-early-detection-blood-test-performance-in-cancer-survivors-from-the-pathfinder-study/ 2025-12-18T08:00:00+00:00 https://grail.com/manuscripts/potential-economic-value-of-multi%e2%80%90cancer-early-detection-testing-under-differential-cost-trends-for-cancer-screening-and-management/ 2025-12-23T08:00:00+00:00 https://grail.com/manuscripts/experience-of-nhs-diagnostic-investigation-following-a-multi-cancer-early-detection-mced-screening-test-qualitative-interviews-with-nhs-galleri-trial-participants-who-had-a-cancer-signal-detected/ 2026-01-08T08:00:00+00:00 https://grail.com/manuscripts/real-world-data-and-clinical-experience-from-over-100000-multi-cancer-early-detection-tests/ 2025-10-31T02:29:00+00:00 https://grail.com/manuscripts/impact-of-population-cancer-risk-on-the-cost-effectiveness-of-multi-cancer-early-detection-testing-in-the-us/ 2025-08-27T07:30:00+00:00 https://grail.com/manuscripts/the-impact-of-cancer-expectations-on-psychological-responses-following-a-cancer-signal-detected-result-in-asymptomatic-multi-cancer-detection-mced-testing/ 2025-09-09T07:30:00+00:00 https://grail.com/manuscripts/durvalumab-after-radiotherapy-in-patients-with-unresectable-stage-iii-non-small-cell-lung-cancer-ineligible-for-chemotherapy-the-duart-phase-ii-nonrandomized-controlled-study/ 2025-08-20T07:00:00+00:00 https://grail.com/manuscripts/intention-to-have-blood-based-multi-cancer-early-detection-mced-screening-among-men-and-women-aged-50-77-years-from-black-and-asian-backgrounds-a-cross-sectional-survey-in-great-britain/ 2025-07-13T02:24:14+00:00 https://grail.com/wp-content/uploads/2025/02/Grail-6-5-scaled-1.jpg https://grail.com/manuscripts/assessment-of-the-impact-of-multi-cancer-early-detection-test-screening-intervals-on-late-stage-cancer-at-diagnosis-and-mortality-using-a-state-transition-model/ 2025-05-08T07:00:00+00:00 https://grail.com/manuscripts/clinical-referral-to-the-nhs-following-multi-cancer-early-detection-test-results-from-the-nhs-galleri-trial/ 2025-05-08T07:00:00+00:00 https://grail.com/manuscripts/modeled-benefit-of-individual-cancer-signal-origin-prediction-for-multi-cancer-early-detection/ 2025-05-05T07:00:00+00:00 https://grail.com/manuscripts/clinical-evaluation-of-cancer-signal-origin-prediction-and-diagnostic-resolution-following-multi-cancer-early-detection-testing-in-the-pathfinder-study/ 2025-04-23T07:00:00+00:00 https://grail.com/manuscripts/navigating-complexity-perspectives-on-risk-assessment-in-the-era-of-new-blood-based-tests-for-early-cancer-detection/ 2025-04-08T07:00:00+00:00 https://grail.com/manuscripts/estimating-the-burden-of-false-positives-and-implementation-costs-from-adding-multiple-single-cancer-tests-or-a-single-multi-cancer-test-to-standard-of-care-screening/ 2025-03-17T08:28:00+00:00 https://grail.com/manuscripts/estimated-proportion-of-cancer-deaths-not-addressed-by-current-cancer-screening-efforts-in-the-united-states/ 2025-03-20T08:27:00+00:00 https://grail.com/manuscripts/psychosocial-impact-associated-with-a-multicancer-early-detection-test-pathfinder-a-prospective-multicentre-cohort-study/ 2025-01-13T13:42:51+00:00 https://grail.com/manuscripts/nhs-galleri-trial-enriched-enrolment-approaches-and-sociodemographic-characteristics-of-enrolled-participants/ 2025-01-25T15:46:50+00:00 https://grail.com/manuscripts/association-of-pre-surgical-circulating-tumor-dna-detection-use-of-sublobar-resection-with-risk-of-recurrence-in-stage-i-non-small-cell-lung-cancer/ 2025-01-13T15:43:17+00:00 https://grail.com/manuscripts/cost-effectiveness-of-a-multicancer-early-detection-test-in-the-us/ 2024-12-13T17:16:46+00:00 https://grail.com/manuscripts/estimating-the-incremental-population-health-impact-of-a-multi-cancer-early-detection-mced-test-to-complement-existing-screening-among-elevated-risk-populations-with-multiple-cancer-risk-fac/ 2024-12-18T12:14:15+00:00 https://grail.com/manuscripts/validity-and-timeliness-of-cancer-diagnosis-data-collected-during-a-prospective-cohort-study-and-reported-by-the-english-and-welsh-cancer-registries-a-retrospective-comparative-analysis/ 2024-10-09T11:07:04+00:00 https://grail.com/manuscripts/lexicon-for-blood-based-early-detection-and-screening-bloodpac-consensus-document/ 2024-08-29T07:35:04+00:00 https://grail.com/manuscripts/perceptions-of-multi-cancer-early-detection-tests-among-communities-facing-barriers-to-health-care/ 2024-08-16T07:35:03+00:00 https://grail.com/manuscripts/intention-to-have-blood-based-multi-cancer-early-detection-mced-screening-a-cross-sectional-population-based-survey-in-england/ 2024-08-27T05:20:57+00:00 https://grail.com/manuscripts/leveraging-multi-cancer-blood-tests-to-improve-diagnostic-efficiency-for-patients-with-nonspecific-signs-and-symptoms/ 2024-08-28T05:20:56+00:00 https://grail.com/manuscripts/a-targeted-methylation-based-multicancer-early-detection-blood-test-preferentially-detects-high-grade-prostate-cancer-while-minimizing-overdiagnosis-of-q1-indolent-disease/ 2024-08-29T05:20:55+00:00 https://grail.com/manuscripts/modeling-the-population-health-impact-of-incorporating-a-multi-cancer-early-detection-mced-test-to-existing-cancer-screening-among-immunocompromised-individuals/ 2024-08-17T11:46:51+00:00 https://grail.com/manuscripts/performance-of-a-multi-cancer-early-detection-test-for-detection-of-hepatocellular-carcinoma-in-patients-with-cirrhosis/ 2024-07-27T08:00:00+00:00 https://grail.com/manuscripts/symptom-impact-and-health-related-quality-of-life-hrqol-assessment-by-cancer-stage-a-narrative-literature-review/ 2024-07-22T08:00:00+00:00 https://grail.com/manuscripts/clinical-utility-of-tumor-naive-pre-surgical-ctdna-detection-in-early-stage-nsclc/ 2024-07-09T06:42:33+00:00 https://grail.com/manuscripts/nonspecific-signs-and-or-symptoms-of-cancer-a-retrospective-observational-analysis-from-a-secondary-care-us-community-oncology-dataset/ 2024-06-25T08:00:00+00:00 https://grail.com/manuscripts/alternative-endpoints-to-mortality-in-cancer-screening-trials/ 2024-07-06T08:00:00+00:00 https://grail.com/manuscripts/overall-and-non-lung-cancer-incidence-and-mortality-in-the-national-lung-screening-trial-opportunities-for-multi-cancer-early-detection/ 2024-06-22T08:00:00+00:00 https://grail.com/manuscripts/enhancing-cancer-prediction-in-challenging-screen-detected-incident-lung-nodules-using-time-series-deep-learning/ 2024-05-20T08:00:00+00:00 https://grail.com/manuscripts/prognostic-implication-of-methylation-based-circulating-tumor-dna-detection-prior-to-surgery-in-stage-i-non-small-cell-lung-cancer/ 2024-05-24T08:00:00+00:00 https://grail.com/manuscripts/strong-association-between-reduction-of-late-stage-cancers-and-reduction-of-cancer-specific-mortality-in-meta-regression-of-randomized-screening-trials-across-multiple-cancer-types/ 2024-05-26T08:00:00+00:00 https://grail.com/manuscripts/a-multi-cancer-early-detection-blood-test-using-machine-learning-detects-early-stage-cancers-lacking-uspstf-recommended-screening/ 2024-04-17T08:25:01+00:00 https://grail.com/manuscripts/attitudes-to-multi-cancer-early-detection-mced-blood-tests-for-population-based-screening-a-qualitative-study-in-great-britain/ 2024-03-12T11:46:50+00:00 https://grail.com/manuscripts/impact-of-screening-participation-on-modelled-mortality-benefits-of-a-multi-cancer-early-detection-test-by-socioeconomic-group-in-england/ 2024-03-01T16:13:34+00:00 https://grail.com/manuscripts/clinical-performance-and-utility-a-microsimulation-model-to-inform-the-design-of-screening-trials-for-a-multi-cancer-early-detection-test/ 2024-02-02T13:53:59+00:00 https://grail.com/manuscripts/avoiding-lead-time-bias-by-estimating-stage-specific-proportions-of-cancer-and-non-cancer-deaths/ 2024-01-18T15:00:00+00:00 https://grail.com/manuscripts/health-state-utilities-associated-with-false-positive-cancer-screening-results/ 2024-01-08T17:04:57+00:00 https://grail.com/manuscripts/a-novel-tissue-free-method-to-estimate-tumor-derived-cell-free-dna-quantity-using-tumor-methylation-patterns/ 2023-12-23T17:00:00+00:00 https://grail.com/manuscripts/megakaryocyte-and-erythroblast-specific-cell-free-dna-patterns-in-plasma-and-platelets-reflect-thrombopoiesis-and-erythropoiesis-levels/ 2023-11-20T09:17:00+00:00 https://grail.com/manuscripts/potential-for-cure-by-stage-across-the-cancer-spectrum-in-the-united-states/ 2023-11-29T14:40:10+00:00 https://grail.com/manuscripts/out-of-pocket-cost-by-cancer-stage-at-diagnosis-in-commercially-insured-patients-in-the-united-states/ 2023-10-31T14:39:49+00:00 https://grail.com/manuscripts/blood-based-tests-for-multicancer-early-detection-pathfinder-a-prospective-cohort-study/ 2023-10-09T08:14:11+00:00 https://grail.com/wp-content/uploads/2022/06/GRAIL-STOCK_Aug2025-21.jpg https://grail.com/manuscripts/multi-cancer-early-detection-test-in-symptomatic-patients-referred-for-cancer-investigation-in-england-and-wales-symplify-a-large-scale-observational-cohort-study/ 2023-06-20T16:29:08+00:00 https://grail.com/wp-content/uploads/2023/05/Screenshot-2025-08-19-at-9.24.46E280AFAM-3.png https://grail.com/manuscripts/the-aggregate-value-of-cancer-screenings-in-the-united-states-full-potential-value-and-value-considering-adherence/ 2023-08-07T16:17:07+00:00 https://grail.com/manuscripts/psychological-impact-of-the-galleri-test-signal-protocol-for-a-longitudinal-evaluation-of-the-psychological-impact-of-receiving-a-cancer-signal-in-the-nhs-galleri-trial/ 2023-07-21T08:30:37+00:00 https://grail.com/manuscripts/performance-of-a-cell-free-dna-based-multi-cancer-detection-test-in-individuals-presenting-with-symptoms-suspicious-for-cancers/ 2023-07-19T09:09:22+00:00 https://grail.com/manuscripts/time-duration-and-health-care-resource-use-during-cancer-diagnoses-in-the-united-states-a-large-claims-database-analysis/ 2023-06-05T16:37:07+00:00 https://grail.com/manuscripts/dying-to-find-out-the-cost-of-time-at-the-dawn-of-the-multicancer-early-detection-era/ 2023-05-31T15:38:00+00:00 https://grail.com/manuscripts/assessment-of-medical-and-public-assistance-expenditures-and-employment-among-us-adults-with-cancer-diagnoses/ 2023-05-26T10:47:30+00:00 https://grail.com/manuscripts/modelled-mortality-benefits-of-multi-cancer-early-detection-screening-in-england/ 2023-04-25T10:19:06+00:00 https://grail.com/manuscripts/dynamic-data-enabled-stratified-sampling-for-trial-invitations-with-application-in-nhs-galleri/ 2023-04-24T08:59:12+00:00 https://grail.com/manuscripts/surgical-resection-as-a-predictor-of-cancer-specific-survival-by-stage-at-diagnosis-and-cancer-type-united-states-2006-2015/ 2023-04-05T11:55:52+00:00 https://grail.com/manuscripts/the-dna-methylome-of-human-vascular-endothelium-and-its-use-in-liquid-biopsies/ 2023-04-14T11:54:08+00:00 https://grail.com/manuscripts/analytical-validation-of-a-multi-cancer-early-detection-test-with-cancer-signal-origin-using-a-cell-free-dna-based-targeted-methylation-assay/ 2023-04-14T08:27:07+00:00 https://grail.com/manuscripts/universal-lung-epithelium-dna-methylation-markers-for-detection-of-lung-damage-in-liquid-biopsies/ 2022-11-03T11:03:01+00:00 https://grail.com/manuscripts/modeled-residual-current-cancer-risk-after-clinical-investigation-of-a-positive-multi-cancer-early-detection-test-result/ 2023-03-21T18:26:45+00:00 https://grail.com/manuscripts/uptake-of-invitations-to-a-lung-health-check-offering-low-dose-ct-lung-cancer-screening-among-an-ethnically-and-socioeconomically-diverse-population-at-risk-of-lung-cancer-in-the-uk-summit-a-prospe/ 2023-02-24T10:34:27+00:00 https://grail.com/manuscripts/performance-of-a-targeted-methylation-based-multi-cancer-early-detection-test-by-race-and-ethnicity/ 2022-12-07T16:40:39+00:00 https://grail.com/manuscripts/detection-of-copd-in-the-summit-study-lung-cancer-screening-cohort-using-symptoms-and-spirometry/ 2022-12-08T08:53:38+00:00 https://grail.com/manuscripts/the-summit-study-utilising-a-written-next-steps-information-booklet-to-prepare-participants-for-potential-lung-cancer-screening-results-and-follow-up/ 2022-12-23T08:50:42+00:00 https://grail.com/manuscripts/a-dna-methylation-atlas-of-normal-human-cell-types/ 2023-01-04T15:22:59+00:00 https://grail.com/manuscripts/cancer-incidence-in-immunocompromised-patients-a-single-center-cohort-study/ 2023-01-09T10:00:36+00:00 https://grail.com/manuscripts/impact-of-early-detection-on-cancer-curability-a-modified-delphi-panel-study/ 2022-12-21T12:40:27+00:00 https://grail.com/manuscripts/telephone-risk-based-eligibility-assessment-for-low-dose-ct-lung-cancer-screening/ 2022-07-21T13:43:09+00:00 https://grail.com/manuscripts/growing-small-solid-nodules-in-lung-cancer-screening-safety-and-efficacy-of-a-200-mm3-minimum-size-threshold-for-multidisciplinary-team-referral/ 2022-11-25T13:41:29+00:00 https://grail.com/manuscripts/evaluation-of-cell-free-dna-approaches-for-multi-cancer-early-detection/ 2022-11-17T12:29:31+00:00 https://grail.com/manuscripts/breast-colorectal-lung-prostate-and-cervical-cancer-screening-prevalence-in-a-large-commercial-and-medicare-advantage-plan-2008-2020/ 2022-11-07T12:27:48+00:00 https://grail.com/manuscripts/multi-cancer-early-detection-test-sensitivity-for-cancers-with-and-without-current-population-level-screening-options/ 2022-10-31T13:08:17+00:00 https://grail.com/manuscripts/bloodpac-collaborating-to-chart-a-path-towards-blood-based-screening-for-early-cancer-detection/ 2022-10-17T09:18:19+00:00 https://grail.com/manuscripts/utilisation-of-primary-care-electronic-patient-records-for-identification-and-targeted-invitation-of-individuals-to-a-lung-cancer-screening-programme/ 2022-09-20T17:01:38+00:00 https://grail.com/manuscripts/cell-free-dna-based-multi-cancer-early-detection-test-in-an-asymptomatic-screening-population-nhs-galleri-design-of-a-pragmatic-prospective-randomised-controlled-trial/ 2022-10-01T10:38:58+00:00 https://grail.com/manuscripts/increased-healthcare-costs-by-later-stage-cancer-diagnosis/ 2022-09-13T11:14:37+00:00 https://grail.com/manuscripts/considerations-in-the-implementation-of-multicancer-early-detection-tests/ 2022-09-05T14:20:11+00:00 https://grail.com/manuscripts/the-potential-value-based-price-of-a-multi-cancer-early-detection-genomic-blood-test-to-complement-current-single-cancer-screening-in-the-usa/ 2022-08-30T11:13:56+00:00 https://grail.com/manuscripts/productivity-loss-and-indirect-costs-for-patients-newly-diagnosed-with-early-versus-late-stage-cancer-in-the-usa-a-large-scale-observational-research-study/ 2022-08-30T11:11:10+00:00 https://grail.com/manuscripts/circulating-tumor-dna-allele-fraction-a-candidate-biological-signal-for-multi-cancer-early-detection-tests-to-assess-the-clinical-significance-of-cancers/ 2022-08-07T10:59:48+00:00 https://grail.com/manuscripts/key-risk-factors-for-the-relative-and-absolute-5-year-risk-of-cancer-to-enhance-cancer-screening-and-prevention/ 2022-08-03T16:08:40+00:00 https://grail.com/manuscripts/patient-preferences-for-multi-cancer-early-detection-mced-screening-tests-journal-the-patient/ 2022-07-18T13:12:47+00:00 https://grail.com/manuscripts/the-reporting-of-pulmonary-nodule-results-by-letter-in-a-lung-cancer-screening-setting/ 2022-04-20T10:00:48+00:00 https://grail.com/manuscripts/patient-reported-outcomes-associated-with-cancer-screening-a-systematic-review/ 2022-03-01T16:37:38+00:00 https://grail.com/manuscripts/cost-of-cancer-management-by-stage-of-diagnosis-among-medicare-beneficiaries/ 2022-03-14T00:00:01+00:00 https://grail.com/manuscripts/manuscript-title-new-genomic-technologies-for-multi-cancer-early-detection-rethinking-the-scope-of-cancer-screening/ 2022-02-03T21:07:49+00:00 https://grail.com/manuscripts/racial-ethnic-differences-in-cancer-diagnosed-after-metastasis-absolute-burden-and-deaths-potentially-avoidable-through-earlier-detection/ 2021-11-19T00:00:43+00:00 https://grail.com/manuscripts/transforming-the-landscape-of-early-cancer-detection-using-blood-tests-commentary-on-current-methodologies-and-future-prospects/ 2021-02-09T20:17:31+00:00 https://grail.com/manuscripts/clinical-correlates-of-circulating-cell-free-dna-tumor-fraction/ 2021-08-25T21:26:00+00:00 https://grail.com/manuscripts/estimating-the-population-health-impact-of-a-multi-cancer-early-detection-genomic-blood-test-to-complement-existing-screening-in-the-us-and-uk/ 2021-08-23T20:44:00+00:00 https://grail.com/manuscripts/the-pathfinder-study-assessment-of-the-implementation-of-an-investigational-multi-cancer-early-detection-test-into-clinical-practice/ 2021-07-13T08:35:36+00:00 https://grail.com/manuscripts/criteria-for-evaluating-multi-cancer-early-detection-tests/ 2021-07-15T17:05:54+00:00 https://grail.com/manuscripts/clinical-validation-of-a-targeted-methylation-based-multi-cancer-early-detection-test-using-an-independent-validation-set/ 2021-06-24T16:01:15+00:00 https://grail.com/manuscripts/health-state-utility-values-by-cancer-stage-a-systematic-literature-review/ 2021-06-14T23:00:09+00:00 https://grail.com/manuscripts/multi-cancer-early-detection-a-new-paradigm-for-reducing-cancer-specific-and-all-cause-mortality-2/ 2021-02-04T18:01:21+00:00 https://grail.com/manuscripts/prognostic-significance-of-blood-based-multi-cancer-detection-in-plasma-cell-free-dna-2/ 2021-06-04T13:00:20+00:00 https://grail.com/manuscripts/a-comprehensive-characterization-of-the-cell-free-transcriptome-reveals-tissue-and-subtype-speci%ef%ac%81c-biomarkers-for-cancer-detection/ 2021-04-21T20:19:11+00:00 https://grail.com/manuscripts/next-generation-sequencing-of-circulating-tumor-dna-for-early-cancer-detection/ 2017-02-09T20:28:57+00:00 https://grail.com/manuscripts/ultra-deep-next-generation-sequencing-of-plasma-cell-free-dna-in-patients-with-advanced-lung-cancers-results-from-the-actionable-genome-consortium/ 2019-03-20T20:28:39+00:00 https://grail.com/manuscripts/high-intensity-sequencing-reveals-the-sources-of-plasma-circulating-cell-free-dna-variants/ 2019-11-25T20:28:15+00:00 https://grail.com/manuscripts/projected-reductions-in-absolute-cancer-related-deaths-from-diagnosing-cancers-before-metastasis-2006-2015/ 2020-03-30T20:27:59+00:00 https://grail.com/manuscripts/sensitive-and-specific-multi-cancer-detection-and-localization-using-methylation-signatures-in-cell-free-dna/ 2020-03-30T20:27:39+00:00 https://grail.com/manuscripts/modeled-reductions-in-late-stage-cancer-with-a-multi-cancer-early-detection-test/ 2020-12-16T20:24:27+00:00